Back to today’s briefing

Story perspectives

CVS Cuts Zepbound Coverage, Patients Face Obesity Treatment Crisis

7/2/2025

42 10

Summary

Story summary

Tara Eacobacci is furious about CVS Caremark's plan to cut insurance coverage for Eli Lilly's Zepbound starting July 1, 2025. This decision jeopardizes obesity treatment, forcing patients to rely on less effective options. While direct-to-consumer sales of Zepbound offer hope amid soaring drug prices, the struggle for affordability continues to loom large.

1 of 1

Story summary

Tara Eacobacci is furious about CVS Caremark's plan to cut insurance coverage for Eli Lilly's Zepbound starting July 1, 2025. This decision jeopardizes obesity treatment, forcing patients to rely on less effective options. While direct-to-consumer sales of Zepbound offer hope amid soaring drug prices, the struggle for affordability continues to loom large.